CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash Flows from Operating Activities:
Net loss	$ (1,034,765)	$ (1,178,793)
Adjustments to reconcile net loss to net cash used in operating activities -
Depreciation and amortization	25,856	21,271
Gain on sale of assets	(32,707)	(27,075)
Stock-based compensation expense	241,388	125,675
Non-cash consulting expense	63,000	66,750
Non-cash gain on settlement of liabilities by issuing common stock	(22,050)	(35,172)
Changes in operating assets and liabilities -
Accounts receivable, net	(162,338)	(56,993)
Inventories	(60,195)	(84,378)
Prepaid expenses	(22,947)	26,740
Accounts payable	261,461	210,958
Customer advances	(118,800)	92,600
Accrued expenses	(14,201)	64,624
Net cash used in operating activities	(876,298)	(773,793)
Cash Flows from Investing Activities:
Proceeds from sale of assets	32,707	27,075
Additional patent costs	(4,230)	(10,972)
Purchases of fixed assets	(4,372)	(62,418)
Net cash provided by (used in) investing activities	24,105	(46,315)
Cash Flows from Financing Activities:
Payment of capital lease obligation	(4,160)	0
Proceeds from private placement of common stock	700,000	980,291
Private placement expenses incurred and paid	(34,639)	(121,512)
Net cash provided by financing activities	661,201	858,779
Net (decrease) increase in cash and cash equivalents	(190,992)	38,671
Cash and cash equivalents, beginning of year	241,051	202,380
Cash and cash equivalents, end of year	50,059	241,051
Supplemental Disclosure of Cash Flow Informatin:
Cash paid during the year for income taxes	912	912
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Issuance of common stock for services rendered to the company	48,300	126,643
Private placement expenses incurred but not yet paid	37,781	6,000
Capital expenditures funded by capital lease borrowings	$ 43,972	$ 0